OEM/ODM Manufacturer Glioblastoma Multiforme - Capecitabine CAS 154361-50-9 Purity 98.0%~102.0% API High Quality – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

We're proud from the higher client fulfillment and wide acceptance due to our persistent pursuit of high quality both on product and service for N"-Dicyclohexylcarbodiimide, Molecular Formula C7H5FO, Sofosbuvir, You may find the lowest price here. Also you will get high quality products and excellent service here! Please do not hesitate to contact us!

OEM/ODM Manufacturer Glioblastoma Multiforme - Capecitabine CAS 154361-50-9 Purity 98.0%~102.0% API High Quality – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Commercial Supply Capecitabine (CAS: 154361-50-9) Related Intermediates:
Capecitabine CAS: 154361-50-9
1,2,3-Triacetyl-5-deoxy-D-ribose CAS: 62211-93-2
2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine CAS: 161599-46-8

Chemical Name	Capecitabine
CAS Number	154361-50-9
CAT Number	RF-API08
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C15H22FN3O6
Molecular Weight	359.35
Brand	Ruifu Chemical

Item	Specifications
Appearance	White Powder
Identification	IR Spectrum Conform to the Standard
Identification	HPLC Conform to the Standard
Purity	98.0%~102.0%
Impurity A	≤0.30%
Impurity B	≤0.30%
Impurity C	≤0.30%
Single Unspecified Impurity	≤0.10%
Total Unspecified Impurities	≤0.50%
Total Impurities	≤1.5%
Moisture (K.F)	≤0.30%
Heavy Metals	≤10ppm
Residue on ignition	≤0.10%
Test Standard	Enterprise Standard
Usage	Capecitabine CAS: 154361-50-9 is widely used in metastatic breast cancer

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Capecitabine is a new form of oral fluorinated pyrimidine drug. Capecitabine was developed by Roche Pharmaceuticals, and its commercial name is Xeloda. Capecitabine can change in vivo into 5- FU, an anti-metabolizim fluorine pyrimidine deoxynucleoside carbamate drug that targets cancer cells to inhibit cell division and disrupt RNA and protein synthesis. Its effects are significantly tied to the level of TP enzyme expression in neoplastic tissue and to DPD enzyme in vivo expression. It is suitable as further treatment for advanced primary or metastatic breast cancer patients who have not responded to paclitaxel or anthracycline antibiotics. As an anticancer drug, it is mostly used to treat advanced primary or metastatic breast cancer, as well as in treatment for non-small cell lung cancer, pancreatic cancer, bladder cancer, rectal cancer, colon cancer, gastric cancer, and other solid tumors. Many drugs such as taxanes (paclitaxel, docetaxel, mitomycin, cisplatin, etc.) can increase TP enzyme expression in neoplastic tissues and also have curative effects on gastric cancer. When used in combination with Capecitabine, these drugs can also improve Capecitabine’s anticancer abilities and produce synergistic effects.

Product detail pictures:

Related Product Guide:

Assume full accountability to satisfy all demands of our consumers; reach ongoing advancements by endorsing the expansion of our purchasers; come to be the final permanent cooperative partner of clients and maximize the interests of clientele for OEM/ODM Manufacturer Glioblastoma Multiforme - Capecitabine CAS 154361-50-9 Purity 98.0%~102.0% API High Quality – Ruifu , The product will supply to all over the world, such as: Wellington, Bangkok, Madagascar, They are sturdy modeling and promoting effectively all over the world. Never ever disappearing major functions within a quick time, it's a have to for you of fantastic good quality. Guided by the principle of Prudence, Efficiency, Union and Innovation. the corporation. ake an excellent efforts to expand its international trade, raise its organization. rofit and raise its export scale. We are confident that we are going to have a bright prospect and to be distributed all over the world in the years to come.